Paul B. Kusserow, Amedisys Inc's CEO and President and a director of the company, recently acquired 11,357 shares of the company. The buys took place at prices ranging from $0.00 to $56.87 per share, on February 20, 2018. Kusserow now owns 90,460 shares of the company. Kusserow operates out of Baton Rouge, LA. Some additional info was provided as follows:
The information in this report is based on a plan statement dated as of December 31, 2017.
Each performance-based restricted share represents a contingent right to receive one share of unrestricted common stock. The performance-based restricted shares shall vest, if at all, based on the certification by the Comensation Committee of the Issuer's Board of Directors of the achievement of identified performance goals fo
r fiscal years 2015 through 2018, respectively (subject to certain pro-rated vesting provisions as provided in the award agreement for the performance-based restricted shares). The performance criteria for fiscal year 2017 were met. The number of performance-based restricted shares listed in Table II, Column 9 represents the maximum number of shares of unrestricted common stock the Reporting Person would receive based on the satisfaction of all of the remaining pre-determined performance goals.
On March 31, 2015, the reporting person was granted an option to purchase 250,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2017 were met, resulting in vesting of the option as to 62,500 shares.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Amedisys Inc makes a similar move, sign up!
Other recent filings from the company include the following:
Amedisys Inc's Chief Human Resources Officer just disposed of 1,050 shares - Aug. 13, 2019
Amedisys Inc's Chief Financial Officer just disposed of 4,871 shares - Aug. 7, 2019
Amedisys Inc's Chief Compliance Officer just disposed of 4,228 shares - Aug. 7, 2019
Amedisys Inc Just Filed Its Quarterly Report: Weighted-Average Sha... - Aug. 1, 2019
Amedisys Reports Second Quarter 2019 Financial Results AND UPDATES 2019 GUIDANCE - July 31, 2019